within Pharmacolibrary.Drugs.ATC.B;

model B05CA09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.03,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Neomycin is an aminoglycoside antibiotic used primarily for its activity against Gram-negative bacteria. It is commonly used for bowel sterilization prior to surgery and for hepatic encephalopathy management; systemic use is limited due to significant toxicity risks, particularly nephrotoxicity and ototoxicity. Neomycin is not used systemically (parenterally) today and is mainly administered orally or topically.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adults, as per best available data, since neomycin is minimally absorbed from the GI tract and published PK studies in humans are lacking.</p><h4>References</h4><ol><li><p>Liu, Y, Yang, Y, Cao, Y, Qiu, J, Kong, J, Zhang, L, Guo, Y, Zhang, M, Cao, X, &amp; Zhang, S (2021). Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine. <i>Journal of veterinary pharmacology and therapeutics</i> 44(5) 850–853. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12981&quot;>10.1111/jvp.12981</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34165196/&quot;>https://pubmed.ncbi.nlm.nih.gov/34165196</a></p></li><li><p>Aschbacher, PW, &amp; Feil, VJ (1994). Neomycin metabolism in calves. <i>Journal of animal science</i> 72(3) 683–689. DOI:<a href=&quot;https://doi.org/10.2527/1994.723683x&quot;>10.2527/1994.723683x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8181985/&quot;>https://pubmed.ncbi.nlm.nih.gov/8181985</a></p></li><li><p>Kavanagh, KT, &amp; McCabe, BF (1983). Ototoxicity of oral neomycin and vancomycin. <i>The Laryngoscope</i> 93(5) 649–653. DOI:<a href=&quot;https://doi.org/10.1002/lary.1983.93.5.649&quot;>10.1002/lary.1983.93.5.649</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6843260/&quot;>https://pubmed.ncbi.nlm.nih.gov/6843260</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B05CA09;
